The multi-provincial influenza drug catalog is officially released, and a number of Chinese patent m

Time:2023-03-13 14:56:49     Views:232

New Media Department           Yu Jie, Duan Yuqing            March 13, 2023

Recently, influenza occurred across the country . Influenza A (H1N1) is the main type, and H3N2 subtype influenza viruses are co-circulating, causing multiple outbreaks in collective units such as primary and secondary schools, and the number of fever clinics in some medical institutions continues to increase. Compared with the common cold, influenza has a longer incubation period, is more contagious, and has more severe symptoms, which can lead to many serious complications such as pneumonia.

In order to give full play to the advantages of Traditional Chinese Medicine and ensure the medical needs of the masses, the bureaus of Traditional Chinese Medicine in Beijing, Shanghai, Sichuan, Hebei and Shaanxi have recently scientifically formulated the guidance plan for the prevention and treatment of influenza with Traditional Chinese Medicine in the spring of 2023 in their provinces (cities). In the plan, well-known anti-epidemic products of Lunan Pharma, such as Jingfang Granules, Xiaoer Xiaoji Zhike Oral Liquid, Xiaoer Kechuanling Oral Liquid/Granules, and Qingre Jiedu Oral Liquid, were selected into the recommended list.

The young but global-oriented Lunan Pharmaceutical Group will achieve new, greater leap in revitalization of national medicine and creating an international century brand.
Copyright © 2022 Lunan Pharmaceutical Group All Rights Reserved.     Design By yunsu